Dr. Kent Brantly's release came two days after a second U.S. missionary, Nancy Writebol, was quietly allowed to leave Emory University Hospital.» Read More
CNBC pharma reporter Meg Tirrell speaks with RBC Capital Markets analyst Michael Yee at the annual ASCO conference about the big moves in drug company stocks on Monday.
In 2012, hospitals charged more for every one of 98 common ailments that could be compared to the previous year.
CNBC biotech & pharma reporter Meg Tirrell talks to Richard Pazdur, the FDA's cancer czar about how far we've come in cancer treatment, breakthrough designations and if chemotherapy will soon be a thing of the past.
Thousands of oncologists, investors, researchers and analysts descended on Chicago for the annual ASCO, the year's biggest cancer research meeting.
CNBC's Meg Tirrell and Daniel O'Day, Roche Holdings COO, discuss the latest developments in immunotherapy and treating bladder cancer.
CNBC's Meg Tirrell and Roger Perlmutter, Merck Research Laboratories president, discuss the latest data on advanced melanoma and which new drugs are in Merck's pipeline.
CNBC's Meg Tirrell and Briggs Morrison, AstraZeneca CMO, discuss Pfizer's failed bid for AstraZeneca and the latest treatment for lung cancer.
Valeant and ally Pershing Square prepared to take its $53.8 billion takeover bid for Allergan directly to shareholders.
In the midst of e-cigarette regulation decisions, the FDA has included lost consumer enjoyment from less smoking in cost-benefit analysis.
Patients can try new once-a-day tablets that dissolve quickly under the tongue and raise tolerance to grass or ragweed pollen, much like the shots.
A new study suggests that applying a tax based on the amount of calories contained in sugary drinks would be effective, the NYT reports.
Religious leaders say the money that would flow to states and businesses if they expanded Medicaid eligibility is just too good to pass up.
The announcement that GSK is planning to spend $350 million plus to get a slice of a U.K. biotech's cancer drugs has raised eyebrows.
As the ASCO meeting gets underway in Chicago, here's a look at where we stand in the fight against cancer.
Fifty-one percent of voters are tired of hearing congressional candidates talk about Obamacare, and want to hear about things like jobs.
A report found the government doled out at least $19 billion in subsidies over 18 years to companies producing key ingredients in junk food.
Health care advocates said on Thursday that four insurers offering plans in the new federal marketplace discriminated against people with H.I.V.
A key theme at this year's ASCO meeting will be immunotherapies. How do these treatments work?
The three physicians ordered so many individual tests that their patients averaged one every other day.
The next place cybercriminals will steal your information is from your doctor’s computer
Get the best of CNBC in your inbox